Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,764,569
+$670,736 QoQ
Shares Held
22,908
-2.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.83%
of 13F equity value
Holder Rank
#1,228
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MEANS INVESTMENT CO., INC. holds $25,645,348 across 8 Drug Manufacturers - General names. ABBV ranks #2 (22.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
28,110 | $7,139,096 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
22,908 | $5,764,569 | |
| 3 | LLY |
ELI LILLY & Co
|
4,726 | $5,668,506 | |
| 4 | MRK |
Merck & Co., Inc.
|
27,981 | $3,595,558 | |
| 5 | NVS |
Novartis AG
|
6,330 | $992,037 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
17,080 | $984,149 | |
| 7 | AMGN |
Amgen Inc
|
2,444 | $885,021 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,879 | $616,412 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,764,569 | 22,908 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,093,833 | 23,421 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $5,490,614 | 24,030 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $5,898,481 | 25,475 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $4,984,082 | 26,851 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $5,621,840 | 26,832 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $4,918,558 | 27,679 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $5,469,603 | 27,697 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $4,726,062 | 27,554 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $5,343,360 | 29,343 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $4,577,813 | 29,540 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $4,387,432 | 29,434 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $3,976,151 | 29,512 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $4,713,527 | 29,576 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $4,763,939 | 29,478 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $3,945,908 | 29,401 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $4,564,627 | 29,803 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $4,866,380 | 30,019 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $4,057,802 | 29,969 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,224,126 | 29,889 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,371,765 | 29,934 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $3,214,999 | 29,708 | Shares | Sole | 2021-04-05 | |
| 2020-12-31 | $3,162,960 | 29,519 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,494,037 | 28,474 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $2,812,758 | 28,649 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,167,148 | 28,444 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||